(c) It potentiates glucose-dependent insulin secretion from the β-cells and inhibits glucagon secretion from the α-cells in the presence of hyperglycemia (increases insulin/glucagon ratio) [252]. The gene discussed is INS; the disease is Hyperglycemia.